1-4 of 4
Diane Cole
Close
Sort by
Journal Articles

Phase I Study of Dose-Adjusted-Teddi-R with Ibrutinib in Untreated and Relapsed/Refractory Primary CNS Lymphoma

Kieron Dunleavy, MD, Catherine E. Lai, MD, Mark Roschewski, MD, Jennifer N Brudno, MD, Brigitte Widemann, MD, Stefania Pittaluga, MD PhD, Elaine S Jaffe, MD, Andrea N Lucas, RN, Maryalice Stetler-Stevenson, MD PhD, Constance M. Yuan, MD PhD, Pamela Harris, MD, Diane Cole, John A Butman, MD, Richard F Little, MD, Louis M Staudt, MD, Wyndham H Wilson, MD PhD
Journal: Blood
Blood (2015) 126 (23): 472.
https://doi.org/10.1182/blood.V126.23.472.472
Published: 2015
Journal Articles

Pharmacokinetics and Tolerability of Etoposide in Newly Diagnosed Lymphoma Patients with Hepatic Impairment

Catherine Lai, MD MPH, Diane Cole, Nicole Lucas, RN, Seth M. Steinberg, PhD, Brigitte C Widemann, MD, Kieron Dunleavy, MD, Wyndham H Wilson, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4445.
https://doi.org/10.1182/blood.V124.21.4445.4445
Published: 2014
Journal Articles

Vincristine Sulfate Liposomes Injection (VSLI, Marqibo): Interim Results From a Phase I Study in Children and Adolescents with Refractory Cancer

Nirali N Shah, MD, Melinda Merchant, MD, PhD, Diane Cole, Kelly Richards, RN, Cindy Delbrook, RN, Brigitte C Widemann, MD, Alan S Wayne, MD
Journal: Blood
Blood (2012) 120 (21): 1497.
https://doi.org/10.1182/blood.V120.21.1497.1497
Published: 2012
Journal Articles

Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy

Wyndham H. Wilson, Michael L. Grossbard, Stefania Pittaluga, Diane Cole, Deborah Pearson, Nicole Drbohlav, Seth M. Steinberg, Richard F. Little, John Janik, Martin Gutierrez, Mark Raffeld, Louis Staudt, Bruce D. Cheson, Dan L. Longo, Nancy Harris, Elaine S. Jaffe, Bruce A. Chabner, Robert Wittes, Frank Balis
Journal: Blood
Blood (2002) 99 (8): 2685–2693.
https://doi.org/10.1182/blood.V99.8.2685
Published: 2002